+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End User (Hospitals, Clinics and Medical Spas, and Others)

  • ID: 5416522
  • Report
  • July 2021
  • Region: North America
  • 148 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • AbbVie Inc.
  • Alma Lasers
  • Candela Medical
  • Cutera Inc.
  • Cynosure
  • Galderma
The injectables segment by diagnosis is estimated to lead the market growth during the forecast period.





According to a new market research study of “North America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Procedure, End-user and Country.” The North America non-invasive aesthetic treatment market is expected to reach US$ 8,085.74 million by 2028 from US$ 3,126.34 million in 2021; it is estimated to grow at a CAGR of 14.5% from 2021 to 2028. The report highlights trends prevailing in the North America non-invasive aesthetic treatment market and the factors driving market along with those that act as hindrances.

The North America non-invasive aesthetic treatment market based on the procedure was segmented into injectables, skin rejuvenation, and others. In 2020, the injectables segment held the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Therefore, the advantages of minimally invasive procedures over conventional surgery - such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate - contribute to the non-invasive aesthetic treatment market growth. As per the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, ~3.8 million minimally invasive cosmetic operations were performed in the US in people with age 55 and above. The advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the North America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.

North America is highly affected due to the COVID-19 outbreak pandemic. In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations distract the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges with diagnostics and bed availability. Moreover, high priorities for the diagnosis and treatment of COVID-19 are leading to decline in non-invasive aesthetic treatment, which is restraining the growth of the North America non-invasive aesthetic treatment market up to certain extent.

The growth of the market is attributed to some key driving factors such as the increasing volume of funding activities for various research studies and other applications, and declining cost of sequencing procedures is expected to boost the sequencing reagents market. However, dearth of skilled professionals is expected to obstruct the growth of the market to a certain extent during the forecast years.

Galderma, Alma Lasers, Merz Pharma, Bausch Health Companies Inc. Cutera Inc. Revance Therapeutics Inc. Cynosure, AbbVie Inc. Candela Medical and Johnson and Johnson Services, Inc. are among the leading companies operating in the North America non-invasive aesthetic treatment market

Reasons to buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America non-invasive aesthetic treatment market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America non-invasive aesthetic treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the North American Non-Invasive Aesthetic Treatment Market

What is the estimated value of the North American Non-Invasive Aesthetic Treatment Market?

The North American Non-Invasive Aesthetic Treatment Market was estimated to be valued at $3126.3 Million in 2021.

What is the growth rate of the North American Non-Invasive Aesthetic Treatment Market?

The growth rate of the North American Non-Invasive Aesthetic Treatment Market is 14.5%, with an estimated value of $8085.7 Million by 2028.

What is the forecasted size of the North American Non-Invasive Aesthetic Treatment Market?

The North American Non-Invasive Aesthetic Treatment Market is estimated to be worth $8085.7 Million by 2028.

Who are the key companies in the North American Non-Invasive Aesthetic Treatment Market?

Key companies in the North American Non-Invasive Aesthetic Treatment Market include Galderma, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., Revance Therapeutics Inc., Cynosure, AbbVie Inc. and Johnson and Johnson Services, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Alma Lasers
  • Candela Medical
  • Cutera Inc.
  • Cynosure
  • Galderma

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Non-invasive Aesthetic Treatment Market - By Procedure
1.3.2 North America Non-invasive Aesthetic Treatment Market - By End User
1.3.3 North America Non-invasive Aesthetic Treatment Market - By Country
2. Non-invasive Aesthetic Treatment Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Non-invasive Aesthetic Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.3 Expert Opinion
5. Non-Invasive Aesthetic Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Number of Non-Invasive Aesthetic/Cosmetic Procedures Performed Every Year
5.1.2 Surge in Awareness About Cosmetic Procedures Among Consumers
5.1.3 Availability of Technologically Advanced Products
5.2 Market Restraints
5.2.1 Clinical Risks and Complications Associated with Medical Aesthetic Procedures
5.3 Market Opportunities
5.3.1 Technological Upgrades and Proliferation of Medical Tourism
5.4 Future Trends
5.4.1 Integration of Telemedicine with Medical Aesthetic Treatment
5.5 Impact Analysis
6. Non-invasive Aesthetic Treatment Market - Global Analysis
6.1 North America Non-invasive Aesthetic Treatment Market Revenue Forecast and Analysis
7. Non-invasive Aesthetic Treatment Market Analysis - By Procedure
7.1 Overview
7.2 Non-invasive Aesthetic Treatment Market, by Diagnosis 2020 & 2028 (%)
7.3 Injectables
7.3.1 Overview
7.3.2 Injectables: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Botulinum Toxin
7.3.3.1 Overview
7.3.3.2 Botulinum Toxin: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Calcium Hydroxylapatite
7.3.4.1 Overview
7.3.4.2 Calcium hydroxylapatite: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Hyaluronic Acid
7.3.5.1 Overview
7.3.5.2 Hyaluronic Acid: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Polymer
7.3.6.1 Overview
7.3.6.2 Polymer: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.3.7 Collagen
7.3.7.1 Overview
7.3.7.2 Collagen: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Skin Rejuvenation
7.4.1 Overview
7.4.2 Skin Rejuvenation: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemical Peels
7.4.3.1 Overview
7.4.3.2 Chemical Peels: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Laser Skin Resurfacing
7.4.4.1 Overview
7.4.4.2 Laser Skin Resurfacing: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Photorejuvenation
7.4.5.1 Overview
7.4.5.2 Photorejuvenation: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Hair Removal
7.5.3.1 Overview
7.5.3.2 Hair Removal: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Nonsurgical Fat Reduction
7.5.4.1 Overview
7.5.4.2 Nonsurgical Fat Reduction: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Sclerotherapy
7.5.5.1 Overview
7.5.5.2 Sclerotherapy: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5.6 Cellulite Treatment
7.5.6.1 Overview
7.5.6.2 Cellulite Treatment: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8. Non-invasive Aesthetic Treatment Market Analysis - By End User
8.1 Overview
8.2 Non-invasive Aesthetic Treatment Market Revenue Share, by End User (2020 and 2028)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Clinics and Medical Spas
8.4.1 Overview
8.4.2 Clinics and Medical Spas: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9. Non-invasive Aesthetic Treatment Market - North America Analysis
9.1 North America: Non-invasive Aesthetic Treatment Market
9.1.1 Overview
9.1.2 North America: Non-invasive Aesthetic Treatment Market, by Country, 2020 & 2028 (%)
9.1.2.1 US: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 US: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 US: Non-invasive Aesthetic Treatment Market, by Procedure, 2019-2028 (USD Million)
9.1.2.1.2.1 US: Non-invasive Aesthetic Treatment Market, by Injectables, 2019-2028 (USD Million)
9.1.2.1.2.2 US: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation, 2019-2028 (USD Million)
9.1.2.1.2.3 US: Non-invasive Aesthetic Treatment Market, by Others, 2019-2028 (USD Million)
9.1.2.1.3 US: Non-invasive Aesthetic Treatment Market, by End User, 2019-2028 (USD Million)
9.1.2.2 Canada: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 Canada: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 Canada: Non-invasive Aesthetic Treatment Market, by Procedure, 2019-2028 (USD Million)
9.1.2.2.2.1 Canada: Non-invasive Aesthetic Treatment Market, by Injectables, 2019-2028 (USD Million)
9.1.2.2.2.2 Canada: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation, 2019-2028 (USD Million)
9.1.2.2.2.3 Canada: Non-invasive Aesthetic Treatment Market, by Others, 2019-2028 (USD Million)
9.1.2.2.3 Canada: Non-invasive Aesthetic Treatment Market, by End User, 2019-2028 (USD Million)
9.1.2.3 Mexico: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 Mexico: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 Mexico: Non-invasive Aesthetic Treatment Market, by Procedure, 2019-2028 (USD Million)
9.1.2.3.2.1 Mexico: Non-invasive Aesthetic Treatment Market, by Injectables, 2019-2028 (USD Million)
9.1.2.3.2.2 Mexico: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation, 2019-2028 (USD Million)
9.1.2.3.2.3 Mexico: Non-invasive Aesthetic Treatment Market, by Others, 2019-2028 (USD Million)
9.1.2.3.3 Mexico: Non-invasive Aesthetic Treatment Market, by End User, 2019-2028 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Non-invasive Aesthetic Treatment Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Non-invasive Aesthetic Market-Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Galderma
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Alma Lasers
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merz Pharma
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bausch Health Companies Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cutera Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Revance Therapeutics Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Cynosure
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Candela Medical
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Johnson and Johnson Services, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms
List of Tables
Table 1. US Non-Invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)
Table 2. US Non-Invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)
Table 3. US Non-Invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)
Table 4. US Non-Invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)
Table 5. US Non-Invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Non-Invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Non-Invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Non-Invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Non-Invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Non-Invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Non-Invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Non-Invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Non-Invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Non-Invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Non-Invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 16. Recent Inorganic Growth Strategies in the of Non-Invasive Aesthetic Treatment Market
Table 17. Recent Organic Growth Strategies in the Non-invasive Aesthetic Treatment Market
Table 18. Glossary of Terms, Non-invasive Aesthetic Treatment Market
List of Figures
Figure 1. Non-invasive Aesthetic Treatment Market Segmentation
Figure 2. Non-invasive Aesthetic Treatment Market, By Country
Figure 3. Non-invasive Aesthetic Treatment Market Overview
Figure 4. Injectable Segment Held Largest Share of the Market by Procedure
Figure 5. North America Non-invasive Aesthetic Treatment Market - Leading Country Markets (USD Million)
Figure 6. North America PEST Analysis
Figure 7. Expert Opinion
Figure 8. Non-invasive Aesthetic Treatment Market Impact Analysis of Drivers and Restraints
Figure 9. North America Non-invasive Aesthetic Treatment Market - Revenue Forecast and Analysis - 2019 - 2028
Figure 10. Non-invasive Aesthetic Treatment Market, by Diagnosis 2020 & 2028 (%)
Figure 11. Injectables: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Botulinum Toxin: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Calcium hydroxylapatite: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Hyaluronic Acid: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Polymer: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Collagen: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Skin Rejuvenation: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Chemical peels: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Laser Skin Resurfacing: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Photorejuvenation: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hair Removal: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Nonsurgical Fat Reduction: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Sclerotherapy: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Cellulite Treatment: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Non-invasive Aesthetic Treatment Market Revenue Share, by End User (2020 and 2028)
Figure 27. Hospitals: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Clinics and Medical Spas: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Others: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America: Non-invasive Aesthetic Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 31. North America: Non-invasive Aesthetic Treatment Market, by Country, 2020 & 2028 (%)
Figure 32. US: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Canada: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Mexico: Non-invasive Aesthetic Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in North American Country Markets
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Galderma
  • Alma Lasers
  • Merz Pharma
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • Revance Therapeutics Inc.
  • Cynosure
  • AbbVie Inc.
  • Candela Medical
  • Johnson and Johnson Services, Inc.
Note: Product cover images may vary from those shown